جست‌وجوی استاد و پژوهشگر

• Alcoholism
• Comorbidity
• Neurobiology
• +۵ مورد دیگر

Ismene Petrakis is a Professor of Psychiatry at Yale School of Medicine and Director of the Mental Health Service Line at VA Connecticut Healthcare System since 2010. She also leads the ACGME-accredited Addiction Psychiatry Residency program at Yale and serves as Principal Investigator for NIAAA- and NIDA-funded training grants . Her clinical and research focus bridges alcohol dependence , comorbid psychiatric disorders , and veterans' health . Research Pillars : Pharmacotherapies for dually diagnosed patients Neurobiological mechanisms of alcoholism PTSD-alcohol comorbidity Genetic risk in substance use Methodological Expertise : Multicenter clinical trials Neurotransmitter system analysis Population-based epidemiology Translational neuroscience Key Publications (2024-2025) : Investigations into GLP1R gene expression in kidney disease Dexmedetomidine for comorbid alcohol-PTSD Cognitive training combinations for alcohol use disorder PTSD treatment effects on neurobiological markers Chronic pain-alcohol use syndemic Collaborative Networks : Yale-Drug use, Addiction, and HIV prevention Research Scholars Neuroscience Research Training Program Collaboration with Department of Anesthesiology

Les A. Gellisمشاهده پروفایل

استاد آموزشی

• Insomnia Treatment
• Sleep Disorders in College Students
• Cognitive Behavioral Interventions
• +۳ مورد دیگر

Les A. Gellis is a Teaching Professor of Psychology at Syracuse University's College of Arts and Sciences. He holds a Ph.D. in Clinical Psychology from the University of Memphis (2006) and a B.A. in Psychology from SUNY Albany (1995). His research focuses on insomnia treatment, sleep behaviors in college students, cognitive interventions, and the intersection of sleep with substance use. Current projects include smartphone app development for sleep measurement and exploring disparities in sleep health. He teaches courses like Abnormal Psychology and Laboratory in Health Psychology. Dr. Gellis has received significant grants, including a National Institute on Alcohol Abuse and Alcoholism award (2019–2025) for studying sleep-alcohol associations in youth. He also leads innovative projects like the sleep experience assessment app funded by CUSE Grants. He actively contributes to academic governance, serving on committees such as the CAS Faculty Council and Psychology Department Strategic Planning Committee. As a clinical supervisor, he oversees the Psychological Services Center and mentors undergraduate research through programs like STAHR-U.

• Addiction Neuroscience
• Neuroimaging
• Psychopharmacology
• +۳ مورد دیگر

Marco Leyton, PhD , is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and the Montreal Neurological Institute and Hospital. He serves as a Professor in the Department of Psychiatry within the Faculty of Medicine and Health Sciences at McGill University . His work focuses on understanding addictions and psychiatric disorders through biopsychosocial frameworks. Institution: RI-MUHC, Montreal Neurological Institute, McGill University Academic Rank: Professor Research Interests : Leyton investigates the neurobiological underpinnings of addiction, emphasizing dopamine and serotonin signaling, neuroimaging techniques (PET, MRI), and vulnerability traits in psychiatric disorders. His studies explore how temperament, adversity, and neurochemical pathways contribute to substance use disorders. Publication Trends : Recent work examines psychedelic drug mechanisms (psilocybin, lisuride), glutamate receptor dynamics, and policy approaches to the overdose crisis. He integrates multimodal imaging (fMRI, PET) to study cue reactivity, cognitive regulation, and developmental trajectories of mental health. Methodological Expertise : Leyton employs advanced neuroimaging, radiotracer development, and longitudinal cohort studies to map neural circuits involved in addiction vulnerability. His research bridges preclinical models with human clinical applications.

Wally Wojciechowskiمشاهده پروفایل

استادیار

• Life-Course Criminology
• Mental Health
• Substance Use and Abuse
• +۵ مورد دیگر

Wally Wojciechowski is an Assistant Professor at the Michigan State University School of Criminal Justice , specializing in life-course criminology and quantitative methodology. His research examines the interplay between mental health, substance use, and violence across developmental stages. PhD in Criminal Justice, 2018, University of Florida MA in Criminal Justice, 2016, University of Florida BA in Criminal Justice, 2012, Central Michigan University Dr. Wojciechowski’s work integrates mental health , substance use , and violence with a focus on adolescent development . His methodological expertise includes longitudinal analysis , mediation processes , and program evaluation , particularly in Michigan and Florida interventions. His recent publications analyze antisocial personality disorder , self-control , and dual systems modeling in predicting polydrug use and offending behaviors . These studies span journals like Journal of Forensic Sciences and Drug and Alcohol Dependence . Dr. Wojciechowski has contributed to understanding age-graded differences in behavioral patterns and has designed evaluation frameworks for promotive programs . No scientific awards are listed in the provided data.

Jen Smithمشاهده پروفایل

عضو هیئت علمی

• Illicit and emerging drugs
• Public Health
• Qualitative Research
• +۳ مورد دیگر

Jen Smith is a Senior Research Fellow at the University of Western Australia (UWA), serving as national coordinator and public health co-lead for the Emerging Drugs Network of Australia (EDNA). Her work focuses on illicit and emerging drug toxicosurveillance, combining clinical toxicology with public health strategy. She holds a PhD in adolescent sexual behavior and pregnancy intentions (2010) and prior roles at Curtin University's School of Public Health. Research & Collaboration : EDNA, a 5-year national collaboration, monitors illicit drug harm in emergency departments (EDs) across five states. Jen's expertise spans qualitative research, policy evaluation (e.g., WA's 'Target 120' initiative), and drug-related health system preparedness. She has published extensively on drug intoxication patterns, clinical predictors of exposure, and emergency medicine protocols. Awards & Recognition : Received the 2024 Vice-Chancellor’s Award for Research Impact and Innovation for contributions to toxicosurveillance. Her work aligns with UN SDGs addressing health and well-being. Key Projects : Includes datasets on ED drug use trends, evaluation of public health initiatives, and collaborations with forensic labs, emergency physicians, and policy bodies.

Steven A. Safrenمشاهده پروفایل

استاد

• HIV/AIDS
• Behavioral Health
• Public Health
• +۶ مورد دیگر

Dr. Steven A. Safren is a Professor at the University of Miami’s College of Arts and Sciences, leading the Safren Lab dedicated to behavioral aspects of physical health. His research focuses on HIV prevention/treatment, psychosocial syndemics, LGBTQ+ health disparities, and medication adherence. The HPAC lab under his direction addresses behavioral interventions for chronic conditions like HIV in high-prevalence areas like Miami, emphasizing structural disparities in ethnicity, economics, and immigration status. Education & Training: Details not explicitly provided in text. PhD in clinical psychology (implied by role and research focus) Research Interests: Dr. Safren’s work bridges behavioral science and public health, particularly in: HIV/AIDS care continuum challenges Intersectionality of stigma and health outcomes among marginalized populations Integrated mental/physical health interventions Syndemic theory application in global health settings Adherence strategies for chronic conditions Lab Activities: Collaborates on projects such as PrEP implementation, LGBTQ-affirmative therapies, and culturally tailored interventions for Latino sexual minority men. Current studies address HIV stigma, substance use comorbidity, and telehealth approaches in behavioral medicine. Grants & Collaborations: Engages in multi-institutional studies funded by NIH and global health agencies, focusing on syndemic impacts and implementation science for HIV prevention. Lab partnerships include work with Sylvester Comprehensive Cancer Center and Miller School of Medicine. Future Work: Expanding research into AI-driven adherence monitoring and scalable behavioral interventions for global HIV populations. Exploring neurocognitive correlates of emotion regulation in chronic illness contexts.

Lisa Eatonمشاهده پروفایل

استاد

• Health and Well-being Development Across the Lifespan
• Advanced Quantitative Methods for Social Sciences
• Ecological Approaches to Disease Prevention
• +۲ مورد دیگر

Lisa Eaton is a Professor in the Department of Human Development and Family Sciences at the University of Connecticut. Her research focuses on health and well-being development across the lifespan, advanced quantitative methods for social sciences, ecological approaches to disease prevention, health disparities interventions, and community-based programs. She holds a PhD from the University of Connecticut (2009) and completed a Post Doctoral Fellowship at Yale University (2010). Education: PhD, University of Connecticut (2009) Post Doctoral Fellowship, Yale University (2010) Dr. Eaton’s recent publications emphasize HIV prevention, stigma reduction, health disparities among sexual and gender minorities, mental health, and intersectional approaches to public health challenges. She explores topics such as PrEP uptake, syndemic theory, structural stigma, and the impact of social determinants on biomedical outcomes. Her work often employs advanced statistical methods like latent profile analysis and geometric intersectional stigma scales. Her articles highlight interventions addressing HIV prevention among Black and Hispanic/Latino populations, including studies on medication adherence, substance use interactions, and the effects of stigma on healthcare engagement. She also investigates broader public health issues like the anti-vaccination movement, pandemic-related healthcare disruptions, and LGBTQ+ youth well-being. Dr. Eaton can be contacted via email at lisa.eaton@uconn.edu .

• Rural Health Disparities
• Epidemiology
• Harm Reduction
• +۴ مورد دیگر

Wiley Jenkins is Professor and Department Chair at Clemson University's College of Behavioral, Social and Health Sciences. His office is located in 510-A Edwards Hall, and he can be contacted via phone (864-656-7117) or email (wileyj@clemson.edu). Dr. Jenkins holds a PhD in Health Policy and Administration from the University of Illinois at Chicago (2007), an MPH in Epidemiology from Tulane University (2002), and a BA in Chemistry and Biology from Blackburn University (1991). He teaches HLTH 8030: Theories and Determinants of Health. Dr. Jenkins' research focuses on rural health disparities with emphasis on: Sexually transmitted infection epidemiology and internet-based interventions Rural cancer disparities and genomic diversity Harm reduction strategies for people who use drugs Health challenges in rural LGBTQ+ communities Translational approaches addressing compounding barriers in vulnerable populations His work examines how social determinants, geographic isolation, and stigma create unique health challenges in underserved rural communities. Recent publication trends show concentrated work on the opioid epidemic through multi-site initiatives like the Rural Opioid Initiative. His research examines: Healthcare access barriers for rural substance users Harm reduction service implementation Infectious disease transmission networks Intersectionality of substance use with housing instability, mental health, and LGBTQ+ disparities Methodological innovations for rural epidemiology Honors include: Frederick P. Li Impact Award (CEBP, 2023) Elected Fellow of American College of Epidemiology (2017) Elected Member of American Association for Cancer Research (2012) Dr. Jenkins leads collaborative research through the Rural Opioid Initiative consortium, examining the fourth wave of the opioid crisis across multiple rural US sites.

Rachel L Gunnمشاهده پروفایل

دانشیار

• Alcohol Use
• Cannabis Use
• Co-Use of Alcohol and Marijuana
• +۴ مورد دیگر

Rachel L Gunn is an Associate Professor holding dual appointments in the Department of Behavioral and Social Sciences (Primary) and Psychiatry and Human Behavior (Secondary) at Brown University. She holds a PhD in Clinical Psychology from Indiana University-Bloomington (2017) and completed clinical training at Brown's Alpert Medical School. Her research focuses on understanding the etiology of alcohol and cannabis use through mixed-method approaches, including laboratory experiments and ambulatory assessments. Current projects investigate simultaneous alcohol/cannabis use impacts, cannabis effects on alcohol treatment outcomes, and perinatal cannabis use mental health consequences. Dr. Gunn's NIH-funded research includes a K08 grant (2019-2024) examining alcohol/cannabis co-use consequences, an R01 (2023-2028) studying cannabis effects on alcohol craving, and a COBRE Pilot Award (2023-2024) exploring perinatal cannabis and postpartum mental health. She collaborates with experts like Jane Metrik, Nancy Barnett, and Lauren Micalizzi on topics spanning substance use patterns, impulsivity, and executive function. Her work integrates behavioral pharmacology, ecological momentary assessment, and longitudinal designs to address real-world substance use dynamics. Notable contributions include demonstrating cannabis's moderating effect on alcohol consumption in clinical settings and clarifying co-use consequences in college populations.

Katherine Hughesمشاهده پروفایل

مدرس ارشد

• Psychopharmacology
• Drug Addiction
• Cognitive Deficits
• +۳ مورد دیگر

Katherine Hughes is a Senior Lecturer at Florida Atlantic University's Charles E. Schmidt College of Science. Her research focuses on the psychopharmacological underpinnings of drug addiction and its treatment, particularly examining cognitive deficits linked to MDMA (Ecstasy) use and the impact of polydrug consumption in recreational and chronic drug users. Research Interests: Hughes investigates the long-term effects of MDMA on cognitive function, comparing these deficits across drug use patterns and exploring how behavioral contingencies and personal motivation influence addiction treatment outcomes. Her work bridges pharmacological mechanisms with behavioral neuroscience to inform clinical approaches. Publication Trends: Her recent studies center on amphetamine-induced hypophagia, analyzing tolerance dynamics, instrumental learning, and neuroadaptation in animal models. These publications highlight her focus on experimental pharmacology and behavioral responses to psychostimulants.

Caren L. Steinmillerمشاهده پروفایل

استاد بالینی

• Substance Abuse
• Pharmacology
• Neuroscience
• +۷ مورد دیگر

Caren L. Steinmiller, Ph.D., is a Clinical Professor in the Department of Pharmacology and Experimental Therapeutics at the University of Toledo 's College of Pharmacy and Pharmaceutical Sciences . She is also designated as a Distinguished University Lecturer since 2020, with prior roles including Associate Lecturer (2014-2020), Lecturer (2011-2014), and Visiting Assistant Professor (2008-2011). Her contact is at the Frederic and Mary Wolfe Center (Room 280B), reachable via phone (419.383.1912) and email (Caren.Steinmiller@utoledo.edu). Ph.D. in Cellular and Clinical Neurobiology, Wayne State University School of Medicine (2001) M.S. in Pharmacology, University of Toledo (1995) B.S. in Biology, University of Toledo (1993) Her research focuses on substance abuse prevention, education, and treatment, particularly examining opioid and cocaine addictions. She applies behavioral economics to analyze drug-seeking behaviors and develops educational frameworks for PharmD admissions . Her work spans neuropharmacology , psychopharmacology , and addiction biology , with a strong emphasis on community outreach and public health education . From 2006-2014, she served as a Research Associate and Post-Doctoral Fellow across multiple institutions, including Wayne State University (mentored by Dr. Mark Greenwald) and the University of Chicago. Her publications (15 most recent) cover opioid relapse mechanisms , behavioral economics of addiction, and neurochemical interactions in drug abuse. Distinguished University Lecturer (2020) Phi Lambda Sigma (2017) Outstanding Faculty Member Award (2015-2016)

Nina O'Neillمشاهده پروفایل

پژوهشگر ارشد

• Drug and Alcohol Research
• Substance Use and Risk
• Interventions and Evaluations
• +۳ مورد دیگر

Nina O'Neill is a Research Fellow at Queen's University Belfast's School of Social Sciences, Education and Social Work. She holds a PhD and has extensive experience managing large-scale research projects, including a NIHR-funded project on novel psychoactive substances. Her work focuses on drug and alcohol research, intervention methodologies, and qualitative inquiry methods. Key areas of expertise include substance use risk analysis, mixed-methods research design, and engagement with vulnerable populations. She has contributed to projects evaluating healthcare interventions for older adults and explored sociocultural impacts of drug policies. Notable collaborations include the NIHR-funded study on NPS use determinants (2015–2017). Research interests bridge clinical trials, public health policy, and qualitative methodologies. Recent work examines educational challenges in Irish-medium schooling and pandemic impacts on prison healthcare systems. She has published in Irish Educational Studies , BMC Geriatrics , and Addiction . Teaching and mentorship activities are not explicitly detailed in her profile, though her project management roles suggest academic leadership. No formal awards are listed, but her contributions to drug policy research demonstrate impactful scholarship.

• Translational health behavior research
• Aboriginal health
• Dementia
• +۶ مورد دیگر

Dr. Megan Freund is a Research Academic with the Health Behaviour Research Collaborative at the School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle. With over 20 years of experience in health behaviour research, Dr. Freund completed her PhD at the University of Newcastle in 2008 and has held significant research fellowships including the HMRI and Newcastle Institute of Public Health Post-Doctoral Research Fellowships (2007-2013) and the NHMRC Translation Research into Practice (TRIP) Fellowship (2018-2019). Dr. Freund's research focuses on translational health behaviour interventions, particularly examining the adoption of efficacious health behaviour interventions into routine practice by service delivery organizations. Her work spans several critical areas including Aboriginal and Torres Strait Islander health, dementia care, gambling behaviors, and health service delivery for vulnerable populations. She has published 78 peer-reviewed papers and secured over $1 million in nationally competitive grant funding from NHMRC and ARC schemes. Her recent research demonstrates a strong focus on Indigenous health, with multiple studies examining mental health and substance use co-occurrence, diabetes management technologies, and dementia care for Aboriginal and Torres Strait Islander communities. She also conducts significant research on social determinants of health, particularly examining health outcomes for people residing in social housing and older adults living in manufactured home villages. NHMRC Translation Research into Practice (TRIP) Fellowship (2018-2019) HMRI Post-Doctoral Research Fellowship (2007-2013) Newcastle Institute of Public Health Post-Doctoral Research Fellowship (2007-2013) Dr. Freund currently supervises one PhD student and has successfully guided six PhD, two master's, and four honors students to completion. She serves as a grant reviewer for multiple national and international funding bodies including NHMRC, ARC, and NIH. Her collaborative work extends to partnerships with Hunter New England Health Service, Centre for Behavioural Research in Cancer Victoria, National Drug and Alcohol Research Centre, and Home in Place social housing provider.

Jennifer Duckworthمشاهده پروفایل

استادیار

• Adolescent Development
• Substance Use Prevention
• Health Risk Behaviors
• +۳ مورد دیگر

Jennifer Duckworth is an Assistant Professor in the Department of Human Development at Washington State University (WSU), affiliated with the College of Agricultural, Human, and Natural Resource Sciences. Her research focuses on adolescent and young adult development, particularly within understudied populations, with a concentration on high-risk alcohol/drug use, sexual behavior, and prevention science. Education: Ph.D., Learning and Developmental Sciences, Indiana University (2018) M.S., Learning and Developmental Sciences, Indiana University (2014) B.S., History, Ball State University (2000) Professional Experience: Postdoctoral Research Fellow (2018–2020): Center for the Studies of Health and Risk Behaviors, University of Washington School of Medicine Research Themes: Her work examines risk/protective factors for substance use, health disparities in marginalized youth, and the interplay between social role transitions and health outcomes. She employs longitudinal designs and diverse sampling strategies to address these issues. Labs/Teams: Active contributor to prevention science initiatives and collaborates with interdisciplinary teams in substance abuse research. Previously affiliated with the University of Washington's Center for Health and Risk Behaviors.

• Cannabis and cannabinoids
• Substance use disorders
• Psychopharmacology
• +۴ مورد دیگر

Ziva D Cooper is a Professor-in-Residence in both the Department of Psychiatry and Biobehavioral Sciences and the Department of Anesthesiology at UCLA's David Geffen School of Medicine. She serves as Vice Chair for Research in Psychiatry and Director of the UCLA Center for Cannabis and Cannabinoids. Dr. Cooper holds a Ph.D. in Biopsychology from the University of Michigan (2007) and completed postdoctoral training in human behavioral pharmacology at Columbia University and the New York State Psychiatric Institute. Her research integrates controlled human studies, observational designs, and preclinical models to investigate therapeutic and adverse effects of psychoactive substances, with emphasis on: Cannabis and cannabinoid pharmacology Opioid-substance interactions Sex-dependent drug effects Substance use disorder mechanisms Clinical trial methodology Pain management alternatives Analysis of her 15 most recent publications reveals predominant themes: cannabis potency effects on mental health (psychosis risk, anxiety modulation), polydrug interactions (alcohol-cannabis co-use), therapeutic applications (pain, depression), public health impacts of legalization, and COVID-19-related behavioral changes. Her work consistently demonstrates methodological rigor through controlled drug-administration paradigms and large-scale epidemiological surveys. Dr. Cooper leads multiple NIH and state-funded projects, including: NIH R01DA057252: Age/sex-dependent THC pharmacodynamics CA DCC-93309: Cannabis concentrate toxicity study NIH R01AT010762: Terpene-THC interactions for pain CA DCC-93306: THC-CBD harm reduction strategies She directs the multidisciplinary UCLA Center for Cannabis and Cannabinoids and maintains active collaborations across neuroscience, public policy, and clinical disciplines.